Back to Rheumatology
Rheumatologyv2000Evidence-Based

Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K)

Stratifies severity of systemic lupus erythematosus (SLE) based on 24 clinical and laboratory parameters, allowing documentation of persistent disease activity.

Clinical Input Parameters

Clinical Assessment
Awaiting Parameters
sledai 2k score
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within rheumatology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

Sum of weighted scores for 24 items (8 points for CNS/vascular, 4 points for renal/musculoskeletal, 2 points for serositis/dermatologic/immunologic, 1 point for constitutional/hematologic)

Clinical Pearls & Practice Notes

  • SLEDAI-2K allows documentation of persistent disease activity in rash, alopecia, mucosal ulcers, and proteinuria
  • The most appropriate cutoff for active disease is 3-4 points
  • A score ≥6 generally indicates need for therapy
  • Scores >45 are uncommon in clinical practice
  • Can use 10-day or 30-day assessment window

Evidence & Literature Citations

  1. Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002 Feb;29(2):288-91.
  2. Buyon JP, Petri MA, Kim MY, Kalunian KC, Grossman J, Hahn BH, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med. 2005 Jun 21;142(12 Pt 1):953-62.
  3. Touma Z, Urowitz MB, Gladman DD. SLEDAI-2K for a 30-day window. Lupus. 2010 Jan;19(1):49-51. doi: 10.1177/0961203309346505.

Score Interpretation Ranges

No Activity0 – 2 pts

No disease activity

Mild Activity3 – 4 pts

Mild disease activity

Moderate Activity5 – 10 pts

Moderate disease activity

High Activity11 – 19 pts

High disease activity

Very High Activity20 – 105 pts

Very high disease activity

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.